Vitas was Chemed’s largest segment in fiscal 2025, bringing in $1.63B of $2.53B (64%).
| Segment Reporting Information, by Segment | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vitas | $1.20B | $1.32B | $1.53B | $1.63B | |||||||||
| Segment Vitas | — | — | — | — | |||||||||
| Roto-Rooter | $933.40M | $949.35M | $900.31M | $899.88M | |||||||||
| Segment Roto-Rooter | — | — | — | — | |||||||||
| Total | $2.13B | $2.26B | $2.43B | $2.53B |
Chemed brought in $2.53B from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 4.1% from $2.43B in fiscal 2024. Vitas was the largest at $1.63B (64.4%), ahead of Roto-Rooter at $899.88M (35.6%).
Compared with fiscal 2024, Vitas grew 6.5% to $1.63B, while Roto-Rooter fell 0.0% to $899.88M. From fiscal 2022 to 2025, combined revenue from these segments grew from $2.13B to $2.53B, a compound annual growth rate of 5.8%. Vitas' share of the total rose from 56.3% to 64.4%.
Guarantor Subsidiaries was Chemed’s largest revenue line in fiscal 2011, bringing in $1.33B of $1.36B (98%).
| Legal Entity | FY 2009 | FY 2010 | FY 2011 |
|---|---|---|---|
| Guarantor Subsidiaries | $1.17B | $1.25B | $1.33B |
| Non-Guarantor Subsidiaries | $23.26M | $25.69M | $27.55M |
| Total | $1.19B | $1.28B | $1.36B |
Chemed brought in $1.36B from its two revenue lines in fiscal 2011, the year ended December 31, 2011. That was up 5.9% from $1.28B in fiscal 2010. Guarantor Subsidiaries was the largest at $1.33B (98.0%), ahead of Non-Guarantor Subsidiaries at $27.55M (2.0%).
Compared with fiscal 2010, Non-Guarantor Subsidiaries grew 7.2% to $27.55M and Guarantor Subsidiaries grew 5.9% to $1.33B. From fiscal 2009 to 2011, combined revenue from these revenue lines grew from $1.19B to $1.36B, a compound annual growth rate of 6.7%. Guarantor Subsidiaries' share held steady at about 98.0%.
Routine Homecare was Chemed’s largest product and service line in fiscal 2017, bringing in $935.91M of $2.10B (45%).
| Product and Service | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|---|
| Routine Homecare | $810.41M | $865.15M | $887.94M | $935.91M | |||
| Short-Term Core Service Jobs | — | — | $345.64M | $373.58M | |||
| Continuous Care | $152.21M | $150.80M | $138.03M | $124.56M | |||
| Plumbing Repair & Maintenance | $174.99M | $188.07M | $197.28M | $219.52M | |||
| Sewer & Drain Cleaning | $141.08M | $142.56M | $145.70M | $151.67M | |||
| General Inpatient | $102.88M | $99.44M | $97.58M | $90.47M | |||
| Water Restoration | $18.48M | $38.16M | $50.23M | $82.27M | |||
| Contractor Revenue | — | — | $40.10M | $43.77M | |||
| Independent Contractors | $36.50M | $37.97M | $40.10M | $43.77M | |||
| Water & Restoration | — | — | — | — | |||
| Other Products & Services | $21.03M | $21.08M | $20.26M | $21.24M | |||
| Other | — | — | $12.51M | $12.71M | |||
| Franchise Fees | — | — | $5.09M | $6.13M | |||
| Hvac Repair & Maintenance | — | — | — | — | |||
| Medicare Cap | -$1.29M | $165.00K | -$228.00K | -$2.68M | |||
| Total | $1.46B | $1.54B | $1.98B | $2.10B |
Chemed brought in $2.10B from its 13 product and service lines in fiscal 2017, the year ended December 31, 2017. That was up 6.2% from $1.98B in fiscal 2016. Routine Homecare was the largest at $935.91M (44.5%), ahead of Short-Term Core Service Jobs at $373.58M (17.8%) and Plumbing Repair & Maintenance at $219.52M (10.4%). The other nine lines brought in $576.59M combined.
Compared with fiscal 2016, Water Restoration grew fastest, up 63.8% to $82.27M, while Continuous Care fell the most, down 9.8% to $124.56M.
Chemed began breaking out Short-Term Core Service Jobs in fiscal 2016, Contractor Revenue in fiscal 2016, Other in fiscal 2016 and Franchise Fees in fiscal 2016. The total is net of Medicare Cap, which took $2.68M off revenue in fiscal 2017.
Chemed (CHE) reports its revenue by segment reporting information, by segment, by legal entity and by product and service. In fiscal 2025, Vitas was its largest segment, bringing in $1.63B (64.4% of the total), followed by Roto-Rooter at $899.88M (35.6%).
Vitas was Chemed's largest segment in fiscal 2025, bringing in $1.63B, or 64.4% of the $2.53B total across its two segments.
Guarantor Subsidiaries was Chemed's largest revenue line in fiscal 2011, bringing in $1.33B, or 98.0% of the $1.36B total across its two revenue lines.
Routine Homecare was Chemed's largest product and service line in fiscal 2017, bringing in $935.91M, or 44.5% of the $2.10B total across its 13 product and service lines.
Vitas grew faster than Roto-Rooter in fiscal 2025, up 6.5% from $1.53B to $1.63B. Roto-Rooter fell 0.0% to $899.88M.
Every figure comes from Chemed's annual financial filings, as reported. Each line keeps the name Chemed gives it, and years follow its fiscal calendar.
Chemed's revenue by segment reporting information, by segment goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.